Literature DB >> 2970963

Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta-thromboglobulin.

A Richmond1, E Balentien, H G Thomas, G Flaggs, D E Barton, J Spiess, R Bordoni, U Francke, R Derynck.   

Abstract

Melanoma growth stimulatory activity (MGSA) is a mitogenic polypeptide secreted by Hs294T human melanoma cells. Comparison of the N-terminal sequences of the 13 and 16 kd MGSA species with the cDNA sequence revealed that the mature form of human MGSA is maximally 73 amino acids long. Expression of the cDNA in mammalian cells results in the secretion of this peptide with mitogenic activity. MGSA is structurally related to the platelet-derived beta-thromboglobulin and to several other polypeptides. These factors may constitute a family of growth factors. MGSA mRNA was detected in a variety of cell types. The level of MGSA mRNA in melanoma cells is strongly elevated by treatment with MGSA. MGSA is the gene product of a recently detected gene gro. The gene was mapped to chromosome 4 (region q13----q21). This same region also contains genes for two of the structurally related factors, for c-kit, a receptor for an as yet unidentified ligand, and for 'piebald trait', an inherited skin pigmentation disorder.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2970963      PMCID: PMC454478          DOI: 10.1002/j.1460-2075.1988.tb03042.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  63 in total

1.  Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor.

Authors:  R F Tucker; G D Shipley; H L Moses; R W Holley
Journal:  Science       Date:  1984-11-09       Impact factor: 47.728

2.  A simple and very efficient method for generating cDNA libraries.

Authors:  U Gubler; B J Hoffman
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

3.  A method for isolation of intact, translationally active ribonucleic acid.

Authors:  G Cathala; J F Savouret; B Mendez; B L West; M Karin; J A Martial; J D Baxter
Journal:  DNA       Date:  1983

4.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

5.  Human chromosomal mapping of genes for insulin-like growth factors I and II and epidermal growth factor.

Authors:  J E Brissenden; A Ullrich; U Francke
Journal:  Nature       Date:  1984 Aug 30-Sep 5       Impact factor: 49.962

6.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

7.  Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factor.

Authors:  C W Castor; J W Miller; D A Walz
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

8.  Assignment of the human gene for the low density lipoprotein receptor to chromosome 19: synteny of a receptor, a ligand, and a genetic disease.

Authors:  U Francke; M S Brown; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

9.  Extraction of a melanoma growth-stimulatory activity from culture medium conditioned by the Hs0294 human melanoma cell line.

Authors:  A Richmond; D H Lawson; D W Nixon; J S Stevens; R K Chawla
Journal:  Cancer Res       Date:  1983-05       Impact factor: 12.701

10.  High efficiency DNA-mediated transformation of primate cells.

Authors:  C Gorman; R Padmanabhan; B H Howard
Journal:  Science       Date:  1983-08-05       Impact factor: 47.728

View more
  82 in total

Review 1.  Chemokines--linking receptors to response.

Authors:  Malcolm L Watson
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

Review 2.  Comparative map for mice and humans.

Authors:  J H Nadeau; M T Davisson; D P Doolittle; P Grant; A L Hillyard; M R Kosowsky; T H Roderick
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

3.  Cloning and sequencing of a new gro transcript from activated human monocytes: expression in leukocytes and wound tissue.

Authors:  N Iida; G R Grotendorst
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

4.  Inflammatory cytokines induce synthesis and secretion of gro protein and a neutrophil chemotactic factor but not beta 2-microglobulin in human synovial cells and fibroblasts.

Authors:  E E Golds; P Mason; P Nyirkos
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

5.  Interleukin-33 induces growth-regulated oncogene-α expression and secretion in human umbilical vein endothelial cells.

Authors:  Masayoshi Yamamoto; Katsuyuki Umebashi; Akinori Tokito; Junichi Imamura; Michihisa Jougasaki
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-06-21       Impact factor: 3.619

6.  Suppression of tumor formation in vivo by expression of the JE gene in malignant cells.

Authors:  B J Rollins; M E Sunday
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

7.  Functional diversity of gro gene expression in human fibroblasts and mammary epithelial cells.

Authors:  A Anisowicz; D Zajchowski; G Stenman; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

8.  The human homolog of the JE gene encodes a monocyte secretory protein.

Authors:  B J Rollins; P Stier; T Ernst; G G Wong
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

9.  Ras activation of genes: Mob-1 as a model.

Authors:  P Liang; L Averboukh; W Zhu; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

10.  Expression of cyr61, a growth factor-inducible immediate-early gene.

Authors:  T P O'Brien; G P Yang; L Sanders; L F Lau
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.